Eduardo L Latouche1, Michael B Sano2,3, Melvin F Lorenzo1, Rafael V Davalos1, Robert C G Martin4. 1. Biomedical Engineering and Mechanics, Virginia Polytechnic Institute and State University, Blacksburg, Virginia. 2. Radiation Oncology, Stanford University School of Medicine, Stanford, California. 3. UNC/NCSU Joint Department of Biomedical Engineering, Chapel Hill, North Carolina. 4. Surgery, Division of Surgical Oncology, University of Louisville, Louisville, Kentucky.
Abstract
BACKGROUND AND OBJECTIVES: Irreversible Electroporation (IRE) is a focal ablation technique highly attractive to surgical oncologists due to its non-thermal nature that allows for eradication of unresectable tumors in a minimally invasive procedure. In this study, our group sought to address the challenge of predicting the ablation volume with IRE for pancreatic procedures. METHODS: In compliance with HIPAA and hospital IRB approval, we established a pre-treatment planning methodology for IRE procedures in pancreas, which optimized treatment protocols for individual cases of locally advanced pancreatic cancer (LAPC). A new method for confirming treatment plans through intraoperative monitoring of tissue resistance was also proved feasible in three patients. RESULTS: Results from computational models showed good correlation with experimental data available in the literature. By implementing the proposed resistance measurement system 210 ± 26.1 (mean ± standard deviation) fewer pulses were delivered per electrode-pair. CONCLUSION: The proposed physics-based pre-treatment plan through finite element analysis and system for actively monitoring resistance changes can be paired to significantly reduce ablation times and risk of thermal effects during IRE procedures for LAPC.
BACKGROUND AND OBJECTIVES: Irreversible Electroporation (IRE) is a focal ablation technique highly attractive to surgical oncologists due to its non-thermal nature that allows for eradication of unresectable tumors in a minimally invasive procedure. In this study, our group sought to address the challenge of predicting the ablation volume with IRE for pancreatic procedures. METHODS: In compliance with HIPAA and hospital IRB approval, we established a pre-treatment planning methodology for IRE procedures in pancreas, which optimized treatment protocols for individual cases of locally advanced pancreatic cancer (LAPC). A new method for confirming treatment plans through intraoperative monitoring of tissue resistance was also proved feasible in three patients. RESULTS: Results from computational models showed good correlation with experimental data available in the literature. By implementing the proposed resistance measurement system 210 ± 26.1 (mean ± standard deviation) fewer pulses were delivered per electrode-pair. CONCLUSION: The proposed physics-based pre-treatment plan through finite element analysis and system for actively monitoring resistance changes can be paired to significantly reduce ablation times and risk of thermal effects during IRE procedures for LAPC.
Authors: Enric Perera-Bel; Carlos Yagüe; Borja Mercadal; Mario Ceresa; Natalie Beitel-White; Rafael V Davalos; Miguel A González Ballester; Antoni Ivorra Journal: Comput Methods Programs Biomed Date: 2020-08-02 Impact factor: 5.428
Authors: Xifu Wang; Zhanliang Su; Tianchu Lyu; Matteo Figini; Daniel Procissi; Junjie Shangguan; Chong Sun; Bin Wang; Na Shang; Shanzhi Gu; Quanhong Ma; Andrew C Gordon; Kai Lin; Jian Wang; Robert J Lewandowski; Riad Salem; Vahid Yaghmai; Andrew C Larson; Zhuoli Zhang Journal: Radiology Date: 2017-12-12 Impact factor: 11.105
Authors: Qi Shao; Feng Liu; Connie Chung; Kianna Elahi-Gedwillo; Paolo P Provenzano; Bruce Forsyth; John C Bischof Journal: Ann Biomed Eng Date: 2017-10-05 Impact factor: 3.934
Authors: Melvin F Lorenzo; Sean C Thomas; Yukitaka Kani; Jonathan Hinckley; Matthew Lee; Joy Adler; Scott S Verbridge; Fang-Chi Hsu; John L Robertson; Rafael V Davalos; John H Rossmeisl Journal: Cancers (Basel) Date: 2019-11-23 Impact factor: 6.639
Authors: Maria Paola Belfiore; Marco De Chiara; Alfonso Reginelli; Alfredo Clemente; Fabrizio Urraro; Roberto Grassi; Giuseppe Belfiore; Salvatore Cappabianca Journal: Front Oncol Date: 2022-09-01 Impact factor: 5.738